DNU Lifestyle

Corporate Vision newsletter

Corporate Vision newsletter

Welcome to issue 7 of Corporate Vision magazine. A monthly publication dedicated to delivering the latest insight and news from across the corporate landscape.

Archive·
Late-stage study of MRNA cancer vaccine begins

Late-stage study of MRNA cancer vaccine begins

Moderna and drugmaker Merck have started a late-stage study to evaluate their experimental mRNA-based cancer vaccine in combination with cancer therapy Keytruda, the companies said on Wednesday.

Archive·